Abliva is dedicated to developing medicines for the treatment of mitochondrial disease, a rare and often severe congenital condition arising from malfunctions in the mitochondria, the cell's energy providers. The company's portfolio encompasses projects in various stages, spanning from early discovery to clinical phases. Abliva's primary focus is to emerge as a leading force in mitochondrial medicine, addressing both mitochond...
Abliva is dedicated to developing medicines for the treatment of mitochondrial disease, a rare and often severe congenital condition arising from malfunctions in the mitochondria, the cell's energy providers. The company's portfolio encompasses projects in various stages, spanning from early discovery to clinical phases. Abliva's primary focus is to emerge as a leading force in mitochondrial medicine, addressing both mitochondrial diseases and orphan indications with significant unmet medical needs.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.